16 related articles for article (PubMed ID: 35587057)
1. BAP18 acting as a novel peroxisome proliferator-activated receptor α co-regulator contributes to hepatocellular carcinoma progression.
Liu W; Wang S; Lin L; Zou R; Sun H; Zeng K; Wu Y; Li Y; Shigeaki K; Wang X; Wang C; Zhao Y
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166974. PubMed ID: 38042310
[TBL] [Abstract][Full Text] [Related]
2. BAP18 facilitates CTCF-mediated chromatin accessible to regulate enhancer activity in breast cancer.
Sun G; Wei Y; Zhou B; Wang M; Luan R; Bai Y; Li H; Wang S; Zheng D; Wang C; Wang S; Zeng K; Liu S; Lin L; He M; Zhang Q; Zhao Y
Cell Death Differ; 2023 May; 30(5):1260-1278. PubMed ID: 36828916
[TBL] [Abstract][Full Text] [Related]
3. BAP18 is involved in upregulation of CCND1/2 transcription to promote cell growth in oral squamous cell carcinoma.
Wang X; Wang C; Yan G; Kang Y; Sun G; Wang S; Zou R; Sun H; Zeng K; Song H; Liu W; Sun N; Liu W; Zhao Y
EBioMedicine; 2020 Mar; 53():102685. PubMed ID: 32113162
[TBL] [Abstract][Full Text] [Related]
4. MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2.
Li YL; Wang J; Zhang CY; Shen YQ; Wang HM; Ding L; Gu YC; Lou JT; Zhao XT; Ma ZL; Jin YX
Oncotarget; 2016 Sep; 7(37):59287-59298. PubMed ID: 27494902
[TBL] [Abstract][Full Text] [Related]
5. miR-466 Contributes to the Enhanced Antitumor Effect of Bortezomib on Non-Small-Cell Lung Cancer by Inhibiting CCND1.
Wang WH; Zhan JM; Tang YL; Zhou N; Liu WY; Jiang DW
Chemotherapy; 2022; 67(2):110-122. PubMed ID: 35042223
[TBL] [Abstract][Full Text] [Related]
6. Aldolase A promotes proliferation and G
Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
[TBL] [Abstract][Full Text] [Related]
7. Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/β-catenin signaling in non-small-cell lung cancer.
Zhao M; Xu P; Liu Z; Zhen Y; Chen Y; Liu Y; Fu Q; Deng X; Liang Z; Li Y; Lin X; Fang W
Cell Death Dis; 2018 Jan; 9(2):78. PubMed ID: 29362431
[TBL] [Abstract][Full Text] [Related]
8. BAP18 induces growth of non-small-cell lung carcinoma through upregulating transcriptional level of CCND1/2.
Wei SJ; Li J; Wang JY; Zhang LX; Zhang HB; Du DJ; Li QX
Eur Rev Med Pharmacol Sci; 2022 May; 26(9):3074-3082. PubMed ID: 35587057
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
